The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells <i>via</i> hCNT1 transporter and multidrug-resistance associated protein MRP-2

Nicolas Skrypek(Ghent University), Nicolas Jonckheere(Centre de Recherche Jean Pierre Aubert)

Oncotarget

March 26, 2015

10.18632/oncotarget.3414

Cited by 41

Related Papers

The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways

|PLoS ONE|2012|59

ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition

|Epigenetics & Chromatin|2018|20

Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma

|Cancers|2021|7